Informed Consent Decision-Making in Deep Brain Stimulation
Open Access
- 11 May 2018
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 8 (5) , 84
Abstract
Deep brain stimulation (DBS) has proved useful for several movement disorders (Parkinson’s disease, essential tremor, dystonia), in which first and/or second line pharmacological treatments were inefficacious. Initial evidence of DBS efficacy exists for refractory obsessive-compulsive disorder, treatment-resistant major depressive disorder, and impulse control disorders. Ethical concerns have been raised about the use of an invasive surgical approach involving the central nervous system in patients with possible impairment in cognitive functioning and decision-making capacity. Most of the disorders in which DBS has been used might present with alterations in memory, attention, and executive functioning, which may have an impact on the mental capacity to give informed consent to neurosurgery. Depression, anxiety, and compulsivity are also common in DBS candidate disorders, and could also be associated with an impaired capacity to consent to treatment or clinical research. Despite these issues, there is limited empirical knowledge on the decision-making levels of these patients. The possible informed consent issues of DBS will be discussed by focusing on the specific treatable diseases.Keywords
This publication has 91 references indexed in Scilit:
- The cognitive side of essential tremor: what are the therapeutic implications?Therapeutic Advances in Neurological Disorders, 2013
- The Relationship Between Executive Functions and Capacity to Consent to Treatment in Acute Psychiatric HospitalizationJournal of Empirical Research on Human Research Ethics, 2012
- The ethics of research on deep brain stimulation for depression: decisional capacity and therapeutic misconceptionAnnals of the New York Academy of Sciences, 2012
- The non-motor syndrome of primary dystonia: clinical and pathophysiological implicationsBrain, 2011
- European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentEuropean Child & Adolescent Psychiatry, 2011
- Ethical issues in deep brain stimulationFrontiers in Integrative Neuroscience, 2011
- The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey ReplicationMolecular Psychiatry, 2008
- Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: Differences among three standards for the MacCAT-CR in patients with schizophreniaSchizophrenia Research, 2007
- Pharmacotherapy of Obsessive-compulsive Disorder and Obsessive-Compulsive Spectrum DisordersPsychiatric Clinics of North America, 2006
- Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized DystoniaNew England Journal of Medicine, 2005